Finance

Lists
Why is GANX down 7,06%?
Dive Deeper
GANX:NASDAQ
Gain Therapeutics Inc
1,64 USD
-7,06%
(-0,12) 1D
29-сен., 12:45:34 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
1,75 USD
High
1,76 USD
Low
1,60 USD
Mkt. cap
71,79 млн
Avg. vol.
365,42 миң
Volume
946,80 миң
52-wk high
4,34 USD
52-wk low
1,53 USD
EPS
-0,51 USD
Beta
0,20
Shares outstanding
43,64 млн
No. of employees
21
Open
1,75 USD
High
1,76 USD
Low
1,60 USD
Mkt. cap
71,79 млн
Avg. vol.
365,42 миң
Volume
946,80 миң
52-wk high
4,34 USD
52-wk low
1,53 USD
EPS
-0,51 USD
Beta
0,20
Shares outstanding
43,64 млн
No. of employees
21
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
Sector-
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current 1,64 USD
8,00 USD (+386,32%)
Average
7,20 USD (+337,69%)
Lowest
5,00 USD (+203,95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
8,00 USD
+386,3%
08/31/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
8,00 USD
+386,3%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
7,00 USD
+325,5%
08/13/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
8,00 USD
+386,3%
08/13/2026
Thomas Shrader
BTIG
Buy
Maintained
5,00 USD
+204%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
2,81 млн
2,32 млн
2,74 млн
2,12 млн
Cost of revenue
2,81 млн
2,32 млн
2,74 млн
2,12 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,98 млн
2,15 млн
2,61 млн
2,56 млн
Operating expense
1,98 млн
2,15 млн
2,61 млн
2,56 млн
Total operating expenses
4,79 млн
4,47 млн
5,35 млн
4,68 млн
Operating income
-4,79 млн
-4,47 млн
-5,35 млн
-4,68 млн
Other non operating income
-
-
-
-
EBT including unusual items
-4,74 млн
-4,47 млн
-5,43 млн
-4,57 млн
EBT excluding unusual items
-4,74 млн
-4,47 млн
-5,43 млн
-4,57 млн
Income tax expense
549,29 миң
70,12 миң
183,07 миң
104,07 миң
Effective tax rate
-11,60%
-1,57%
-3,37%
-2,28%
Other operating expenses
-
-
-
-
Net income
-5,28 млн
-4,54 млн
-5,61 млн
-4,68 млн
Net profit margin
-
-
-
-
Earnings per share
-0,15
-0,11
-0,13
-0,11
Interest and investment income
83,30 миң
88,58 миң
93,34 миң
60,73 миң
Interest expense
-
-
-
-
Net interest expenses
83,30 миң
88,58 миң
93,34 миң
60,73 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,78 млн
-4,46 млн
-5,34 млн
-4,67 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору